Bastian Klaan

Dr. Bastian Klaan

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2019 in Cancers
Verified
Journal Article
Open access
PDF file
SFSarah O. Fischer
Sarah O. Fischer
MTMohamed Tahoun
Mohamed Tahoun
BKBastian Klaan
Bastian Klaan
KTKolja M. Thierfelder
Kolja M. Thierfelder
MWMarc André Weber
Marc André Weber
MHMohamed Hamed
Mohamed Hamed
Prostate cancer (PCa) is a genetically heterogeneous cancer entity that causes challenges in pre-treatment clinical evaluation, such as the correct identification of the tumor stage. Conventional clinical tests based on digital rectal examination, Prostate-Specific Antigen (PSA) levels, and Gleason score still lack accuracy for stage prediction. We hypothesize that unraveling the molecular mechanisms underlying PCa staging via integrative analysis of multi-OMICs data could significantly improve the prediction accuracy for PCa pathological stages. We present a radiogenomic approach comprising clinical, imaging, and two genomic (gene and miRNA expression) datasets for 298 PCa patients. Comprehensive analysis of gene and miRNA expression profiles for two frequent PCa stages (T2c and T3b) unraveled the molecular characteristics for each stage and the corresponding gene regulatory interaction network that may drive tumor upstaging from T2c to T3b. Furthermore, four biomarkers (ANPEP, mir-217, mir-592, mir-6715b) were found to distinguish between the two PCa stages and were highly correlated (average r = ± 0.75) with corresponding aggressiveness-related imaging features in both tumor stages. When combined with related clinical features, these biomarkers markedly improved the prediction accuracy for the pathological stage. Our prediction model exhibits high potential to yield clinically relevant results for characterizing PCa aggressiveness.

8 July 2019 in Der Radiologe
Verified
Journal Article
Closed access
PDF file
BKBastian Klaan
Bastian Klaan
FWF. Wuennemann
F. Wuennemann
LKL. Kintzelé
L. Kintzelé
AGA. S. Gersing
A. S. Gersing
MWM.-A. Weber
M.-A. Weber

14 July 2026 in Life
Verified
Journal Article
Open access
PDF file
ABAnn-Kristin Becker
Ann-Kristin Becker
BKBastian Klaan
Bastian Klaan
ISIman Soodmand
Iman Soodmand
CLChris Lappe
Chris Lappe
DCDaniel Cantré
Daniel Cantré
MKMaeruan Kebbach
Maeruan Kebbach
Finite element (FE) modeling is widely used in biomechanical research, enabling computational investigations of anatomical structures. To develop accurate FE models, high-resolution medical imaging such as computed tomography (CT) is essential. However, CT exposes patients to ionizing radiation. Recently, radiation-free three-dimensional zero-echo-time magnetic resonance imaging (3D ZTE MRI) has shown promising results for bone visualization. Therefore, this feasibility study investigated whether 3D ZTE MRI is reliable for creating subject-specific FE models. Human femora from four female subjects were imaged using 3D ZTE MRI. Static FE analyses of the femora were performed in Abaqus/CAE, assuming a biphasic homogenous linear-elastic material. A sensitivity analysis was conducted to evaluate varying bone material properties. After loading with 2000 N, the mean displacement of the femoral head amounted to −1.30 ± 0.26 mm (vertical) and −9.03 ± 2.21 mm (horizontal), while the femoral neck exhibited compressive (inferior: −1366.03 ± 182.70 µm/m) and tensile (superior: 1038.69 ± 135.82 µm/m) strains. Overall, the results demonstrate displacement and strain predictions similar to previous experimental and computational studies based on CT data. Therefore, despite several simplifications, these findings confirm the feasibility of radiation-free 3D ZTE MRI for subject-specific FE modeling, enabling future simultaneous assessment of bone morphology and surrounding soft tissues.